L'accès aux traitements antisida en Afrique: une analyse de la stratégie de brevet des entreprises multinationales

Samira Guennif () and Claude Mfuka

Mondes en développement, 2005, vol. 131, issue 3, 75-86

Abstract: According to Attaran and Gillespie-White (2001), there is no link between patents and poor access to HIV/AIDS treatments in Africa since multinationals patent a few. Questioning what the authors call the rule and the exceptions, this paper shows that multinationals use patents as entry barriers towards southern generics producers, which impedes access to medicines and hinders the industrial development of these generics producers.

Keywords: patent; strategy; multinationals; Africa; generics producers; antiretrovirals (search for similar items in EconPapers)
Date: 2005
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=MED_131_0075 (application/pdf)
http://www.cairn.info/revue-mondes-en-developpement-2005-3-page-75.htm (text/html)
free

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:meddbu:med_131_0075

Access Statistics for this article

More articles in Mondes en développement from De Boeck Université
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().